1 |
Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism 2016;65(8):1096-1108.
DOI
|
2 |
Ducharme NA, Bickel PE. Minireview: lipid droplets in lipogenesis and lipolysis. Endocrinology 2008;149(3):942-949.
DOI
|
3 |
Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005;54(8):2460-2470.
DOI
|
4 |
Day EA, Ford RJ, Steinberg GR. AMPK as a therapeutic target for treating metabolic diseases. Trends in Endocrinology & Metabolism 2017;28(8):545-560.
DOI
|
5 |
Wang Z, Pini M, Yao T, Zhou Z, Sun C, Fantuzzi G, Song Z. Homocysteine suppresses lipolysis in adipocytes by activating the AMPK pathway. American journal of physiology-endocrinology and metabolism 2011;301(4):E703-E712.
DOI
|
6 |
Brunt EM. Nonalcoholic fatty liver disease: pros and cons of histologic systems of evaluation. International journal of molecular sciences 2016;17(1):97.
DOI
|
7 |
Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nature medicine 2004;10(4):355-361.
DOI
|
8 |
Choi SS, Diehl AM. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Current opinion in lipidology 2008;19(3):295-300.
DOI
|
9 |
Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. The Journal of clinical investigation 2006;116(3):615-622.
DOI
|
10 |
Smith BK, Marcinko K, Desjardins EM, Lally JS, Ford RJ, Steinberg GR. Treatment of nonalcoholic fatty liver disease: role of AMPK. American Journal of Physiology-Endocrinology and Metabolism 2016;311(4):E730-E740.
DOI
|
11 |
Gui Y, Pan Q, Chen X, Xu S, Luo X, Chen L. The association between obesity related adipokines and risk of breast cancer: a meta-analysis. Oncotarget 2017;8(43):75389.
DOI
|
12 |
Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. The Journal of clinical investigation 2008;118(3):829-838.
DOI
|
13 |
Tian J, Goldstein JL, Brown MS. Insulin induction of SREBP-1c in rodent liver requires LXRα-C/EBPβ complex. Proceedings of the National Academy of Sciences 2016;113(29):8182-8187.
DOI
|
14 |
Kim CS, Cho EH, Choe SY, Kang MS, Yu R. Inhibitory effect of isorhamnetin on lipid accumulation in free fatty acid-induced steatotic hepatocytes through the PPARα pathway. Journal of the Korean Society of Food Science and Nutrition 2018;47(7):703-709.
DOI
|
15 |
Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends in endocrinology & metabolism 2008;19(2):65-73.
DOI
|
16 |
Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. The Journal of clinical investigation 2004;114(2):147-152.
DOI
|
17 |
Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. The Journal of clinical investigation 2006;116(7):1776-1783.
DOI
|
18 |
Foretz M, Viollet B. Regulation of hepatic metabolism by AMPK. Journal of Hepatology 2011;54(4):827-9.
DOI
|
19 |
Cherkaoui-Malki M, Surapureddi S, I El Hajj H, Vamecq J, Andreoletti P. Hepatic steatosis and peroxisomal fatty acid beta-oxidation. Current Drug Metabolism 2012;13(10):1412-1421.
DOI
|
20 |
Szkudelski T, Szkudelska K. Effects of AMPK activation on lipolysis in primary rat adipocytes: studies at different glucose concentrations. Archives of physiology and biochemistry 2017;123(1):43-49.
DOI
|
21 |
Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, Spalding D. Non-alcoholic fatty liver disease: a sign of systemic disease. Metabolism 2017;72:94-108.
DOI
|
22 |
Cho MS, Park RJ, Park SH, Cho YH, Cheng GA. The effect of microcurrent-inducing shoes on fatigue and pain in middle-aged people with plantar fascitis. Journal of Physical Therapy Science 2007;19(2):165-170.
DOI
|
23 |
Oh HJ, Kim JY, Park RJ. The effects of microcurrent stimulation on recovery of function and pain in chronic low back pain. Journal of the Korean Society of Physical Medicine 2008;3(1):47-56.
|
24 |
김한성 외, 세포 전기자극 시스템 및 방법, 대한민국 특허청 등록특허공보 등록번호 10-2101372, 2020.
|
25 |
Yoo KD, Jun DW. Nonalcoholic Fatty Liver Disease: Lifestyle Modification. Korean Journal of Medicine 2014;86(4):416-424.
DOI
|
26 |
Lin HTV, Tsou YC, Chen YT, Lu WJ, Hwang PA. Effects of low-molecular-weight fucoidan and high stability fucoxanthin on glucose homeostasis, lipid metabolism, and liver function in a mouse model of type II diabetes. Marine drugs 2017;15(4):113.
DOI
|
27 |
He XX, Wu XL, Chen RP, Chen C, Liu XG, Wu BJ, Huang ZM. Effectiveness of omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. PLoS One 2016;11(10):e0162368.
DOI
|
28 |
Yeh YT, Cho YY, Hsieh SC, Chiang AN. Chinese olive extract ameliorates hepatic lipid accumulation in vitro and in vivo by regulating lipid metabolism. Scientific reports 2018;8(1):1-13.
|
29 |
Yoo A, Narayan VP, Hong EY, Whang WK, Park T. Scopolin ameliorates high-fat diet induced hepatic steatosis in mice: potential involvement of SIRT1-mediated signaling cascades in the liver. Scientific reports 2017;7(1):1-11.
DOI
|
30 |
Chen H, Liu X, Chen H, Cao J, Zhang L, Hu X, Wang J. Role of SIRT1 and AMPK in mesenchymal stem cells differentiation. Ageing research reviews 2014;13:55-64.
DOI
|
31 |
Peng IC, Chen Z, Sun W, Li YS, Marin TL, Hsu PH, Shyy JY. Glucagon regulates ACC activity in adipocytes through the CAMKKβ/AMPK pathway. American Journal of Physiology-Endocrinology and Metabolism 2012;302(12):E1560-E1568.
DOI
|
32 |
Huang WC, Chang WT, Wu SJ, Xu PY, Ting NC, Liou CJ. Phloretin and phlorizin promote lipolysis and inhibit inflammation in mouse 3T3-L1 cells and in macrophage-adipocyte co-cultures. Molecular nutrition & food research 2013;57(10):1803-1813.
DOI
|
33 |
Houten SM, Violante S, Ventura FV, Wanders RJ. The biochemistry and physiology of mitochondrial fatty acid β-oxidation and its genetic disorders. Annual review of physiology 2016;78:23-44.
DOI
|
34 |
Fruhbeck G, Mendez-Gimenez L, Fernandez-Formoso JA, Fernandez S, Rodriguez A. Regulation of adipocyte lipolysis. Nutrition research reviews 2014;27(1):63-93.
DOI
|
35 |
Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Herrero L. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. American Journal of Physiology-Endocrinology and Metabolism 2015;308(9):E756-E769.
DOI
|
36 |
Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 2007;27:79-101.
DOI
|
37 |
Heindel JJ, Newbold R, Schug TT. Endocrine disruptors and obesity. Nature Reviews Endocrinology 2015;11(11):653-661.
DOI
|
38 |
Li YU, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Zang M. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell metabolism 2011;13(4):376-388.
DOI
|
39 |
Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Herrero L. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. American Journal of Physiology-Endocrinology and Metabolism 2015;308(9):E756-E769.
DOI
|
40 |
Wang Y, Viscarra J, Kim SJ, Sul HS. Transcriptional regulation of hepatic lipogenesis. Nature reviews Molecular cell biology 2015;16(11):678-689.
DOI
|
41 |
Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC. Fisetin protects against hepatic steatosis through regulation of the Sirt1/AMPK and fatty acid β-oxidation signaling pathway in high-fat diet-induced obese mice. Cellular physiology and biochemistry 2018;49(5):1870-1884.
DOI
|
42 |
Herbrechter R, Ziemba PM, Hoffmann KM, Hatt H, Werner M, Gisselmann, G. Identification of Glycyrrhiza as the rikkunshito constituent with the highest antagonistic potential on heterologously expressed 5-HT3A receptors due to the action of flavonoids. Frontiers in pharmacology 2015;6:130.
|
43 |
Gaidhu MP, Fediuc S, Anthony NM, So M, Mirpourian M, Perry RL, Ceddia RB. Prolonged AICAR-induced AMPkinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. Journal of lipid research 2009;50(4):704-715.
DOI
|
44 |
Hwang D, Lee H, Lee M, Cho S, Kim HS. The Micro-Current Stimulation Inhibits Adipogenesis by Activating Wnt/ β-Catenin Signaling. Journal of Biomedical Engineering Research 2020;41(6):235-246.
DOI
|
45 |
Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments. Nutrients 2017;9(4):387.
DOI
|
46 |
Lim CT, Kola B, Korbonits M. AMPK as a mediator of hormonal signalling. Journal of molecular endocrinology 2010;44(2):87.
|
47 |
Lampidonis AD, Rogdakis E, Voutsinas GE, Stravopodis DJ. The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis. Gene 2011;477(1-2):1-11.
DOI
|
48 |
Li Y, Zhu W, Li J, Liu M, Wei M. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1. Oncology reports 2013;30(6):2820-2828.
DOI
|